Billboards with pictures of Prime Minister Narendra Modi have been put up in the Greater Toronto area to thank him after India sent 5,00,000 doses of Covishield.
Covishield is manufactured by Pune-based Serum Institute of India. Pakistan will get 4.5 crore doses of the drug under GAVI alliance.
Reacting to reports that the state may run out of vaccines, the union government clarified on Tuesday that there is no shortage of Covid-19 vaccines in Rajasthan.
Coronavirus vaccination drive: The next phase of COVID-19 vaccination commenced from March for those above 60 years of age and for people aged 45 and above with specified comorbid conditions.
Delhi Chief Minister Arvind Kejriwal on Thursday received the first dose of the Covid-19 vaccine at LNJP hospital.
Vaccines are being provided free of charge at the government health facilities and on a payment basis in the private health facilities. All private hospitals can charge Rs 150 for vaccines and Rs 100 for service charges fixed by the central government.
Covishield and Covaxin are two anti-coronavirus vaccines approved by the DGCI for emergency use in India. PM Modi received a Covaxin jab.
The government is upgrading the CoWIN which was being used in the initial two phases of the vaccination for immunisation of healthcare and frontline workers.
The NITI Aayog has promulgated a price range of Rs 300-500 for two Covid vaccines that would be available for the priority group at private facilities in the third phase of vaccination set to begin from March 1, sources privy to the development told IANS, adding that the Bharat Biotech's Covaxin would cost a bit higher.
India is one of the world's biggest drugmakers, and an increasing number of countries have already approached it for procuring anti-coronavirus vaccines.
India launched the world's largest vaccination drive on January 16 for the healthcare and frontline workers. According to government data, over 11 lakh people have been administered two doses of Covid vaccines so far.
India has approved two vaccines -- Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India -- for emergency use in the country.
Minister of State for Health Ashwini Choubey was responding to a question on whether the government is aware that the Oxford-AstraZeneca vaccine is being sold to European Union nations at comparatively lower price that to India.
Canadian Prime Minister Justin Trudeau on Wednesday called on Prime Minister Narendra Modi and shared Canada's requirements of COVID-19 vaccines from India.
During the initial phases, the vaccine is being provided to the priority groups of healthcare and frontline workers for free by the central government.
The most vulnerable age group of people in the country, those aged above 50 will get the first jab in March second week onwards, Union Health Minister Harsh Vardhan informed Parliament on Friday.
The second dose of coronavirus vaccine will be administered to healthcare workers from February 13, Dr VK Paul, Member, NITI Aayog informed on Thursday.
A civil court in Pune on Saturday rejected an injunction application filed on behalf of pharmaceutical company Cutis Biotech against the Serum Institute of India, seeking the latter to restrain from using the trademark 'Covishield' for its Covid-19 vaccine.
Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has become the first immune dose to definitively confirm protection against the new variant of the deadly virus which was detected in the UK late last year.
The Union Health Ministry on Friday asked all states and union territories to initiate vaccination of frontline workers against COVID-19 from the first week of February.
Top News
Latest News
